This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.
Newly diagnosed stage I-III breast cancer.
Treatment-naïve; no neoadjuvant therapy planned.
Surgery scheduled at Moffitt in 1-2 months.
Post-menopausal.
Stage IV/metastatic disease.
Prior cancer.
Surgery scheduled sooner than 4-5 weeks.
NCI FVS ≥5 servings/day.
Single group
Mediterranean Diet
Other interventionA two-week cyclic menu (14 unique days of meals repeated) approach will be used for the Mediterranean diet intervention. Participants will be provided with 3 meals a day and receive daily snacks to consume.
Feasibility of Enrollment
Percentage of eligible participants who enroll.
Retention
Percentage of enrolled participants will complete assessments at both timepoints
Adherence
Percentage of participants who consume ≥70% of study meals.
Acceptability
Percentage of participants who rate overall satisfaction as "agree" and "strongly agree."
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
